Elena Somma
Family Medicine · Roseville, CANPI 1659417996
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $842 and has fallen 89.7% since, to $87 in 2022.
Across 101 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$378
- Astellas Pharma US Inc$183
- GSK$141
- AbbVie$130
- AstraZeneca$128
- Boehringer Ingelheim$118
- plus $688 from 21 others
What the payments were for
- Food & beverage$1,767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $378 |
| Astellas Pharma US Inc | 10 | $183 |
| GSK | 8 | $141 |
| AbbVie(2 entities) | 6 | $130 |
| AstraZeneca | 7 | $128 |
| Boehringer Ingelheim | 7 | $118 |
| Merck | 5 | $90 |
| Novartis | 4 | $75 |
| Pfizer | 3 | $72 |
| Lilly USA, LLC | 4 | $71 |
| Amgen | 2 | $51 |
| Amarin Pharma, Inc. | 3 | $41 |
| Sanofi Pasteur Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Abbott | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Bausch Health US, LLC | 1 | $12 |
| Seqirus USA Inc | 1 | $11 |
How this compares
$1,767 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Other family medicine in Roseville
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.